Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Major Manufacturers Covered in This Report
• 1.3 Market Segment by Type
  • 1.3.1 Global Meloxicam Drug Market Size Growth Rate by Type (2019-2025)
  • 1.3.2 Tablet
  • 1.3.3 Capsule
• 1.4 Market Segment by Application
  • 1.4.1 Global Meloxicam Drug Market Share by Application (2019-2025)
  • 1.4.2 Osteoarthritis in adults (OA)
  • 1.4.3 Rheumatoid Arthritis in adults (RA)
  • 1.4.4 Pediatric patients
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Growth Trends

• 2.1 Global Meloxicam Drug Market Size
  • 2.1.1 Global Meloxicam Drug Revenue 2014-2025
  • 2.1.2 Global Meloxicam Drug Sales 2014-2025
• 2.2 Meloxicam Drug Growth Rate by Regions
  • 2.2.1 Global Meloxicam Drug Sales by Regions 2014-2019
  • 2.2.2 Global Meloxicam Drug Revenue by Regions 2014-2019
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers

3 Market Share by Manufacturers

• 3.1 Meloxicam Drug Sales by Manufacturers
  • 3.1.1 Meloxicam Drug Sales by Manufacturers 2014-2019
  • 3.1.2 Meloxicam Drug Sales Market Share by Manufacturers 2014-2019
• 3.2 Revenue by Manufacturers
  • 3.2.1 Meloxicam Drug Revenue by Manufacturers (2014-2019)
  • 3.2.2 Meloxicam Drug Revenue Share by Manufacturers (2014-2019)
  • 3.2.3 Global Meloxicam Drug Market Concentration Ratio (CR5 and HHI)
• 3.3 Meloxicam Drug Price by Manufacturers
• 3.4 Key Manufacturers Meloxicam Drug Plants/Factories Distribution and Area Served
• 3.5 Date of Key Manufacturers Enter into Meloxicam Drug Market
• 3.6 Key Manufacturers Meloxicam Drug Product Offered
• 3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Sales and Revenue for Each Type
  • 4.1.1 Tablet Sales and Revenue (2014-2019)
  • 4.1.2 Capsule Sales and Revenue (2014-2019)
• 4.2 Global Meloxicam Drug Sales Market Share by Type
• 4.3 Global Meloxicam Drug Revenue Market Share by Type
• 4.4 Meloxicam Drug Price by Type

5 Market Size by Application

• 5.1 Overview
• 5.2 Global Meloxicam Drug Sales by Application

6 United States

• 6.1 United States Meloxicam Drug Breakdown Data by Company
• 6.2 United States Meloxicam Drug Breakdown Data by Type
• 6.3 United States Meloxicam Drug Breakdown Data by Application

7 European Union

• 7.1 European Union Meloxicam Drug Breakdown Data by Company
• 7.2 European Union Meloxicam Drug Breakdown Data by Type
• 7.3 European Union Meloxicam Drug Breakdown Data by Application

8 China

• 8.1 China Meloxicam Drug Breakdown Data by Company
• 8.2 China Meloxicam Drug Breakdown Data by Type
• 8.3 China Meloxicam Drug Breakdown Data by Application

9 Rest of World

• 9.1 Rest of World Meloxicam Drug Breakdown Data by Company
• 9.2 Rest of World Meloxicam Drug Breakdown Data by Type
• 9.3 Rest of World Meloxicam Drug Breakdown Data by Application
• 9.4 Rest of World Meloxicam Drug Breakdown Data by Countries
  • 9.4.1 Rest of World Meloxicam Drug Sales by Countries
  • 9.4.2 Rest of World Meloxicam Drug Revenue by Countries
  • 9.4.3 Japan
  • 9.4.4 Korea
  • 9.4.5 India
  • 9.4.6 Southeast Asia

10 Company Profiles

• 10.1 Boehringer-Ingelheim
  • 10.1.1 Boehringer-Ingelheim Company Details
  • 10.1.2 Company Description and Business Overview
  • 10.1.3 Sales, Revenue and Market Share of Meloxicam Drug
  • 10.1.4 Meloxicam Drug Product Introduction
  • 10.1.5 Boehringer-Ingelheim Recent Development
• 10.2 TerSera Therapeutics
  • 10.2.1 TerSera Therapeutics Company Details
  • 10.2.2 Company Description and Business Overview
  • 10.2.3 Sales, Revenue and Market Share of Meloxicam Drug
  • 10.2.4 Meloxicam Drug Product Introduction
  • 10.2.5 TerSera Therapeutics Recent Development
• 10.3 Iroko Pharmaceuticals
  • 10.3.1 Iroko Pharmaceuticals Company Details
  • 10.3.2 Company Description and Business Overview
  • 10.3.3 Sales, Revenue and Market Share of Meloxicam Drug
  • 10.3.4 Meloxicam Drug Product Introduction
  • 10.3.5 Iroko Pharmaceuticals Recent Development
• 10.4 Apotex
  • 10.4.1 Apotex Company Details
  • 10.4.2 Company Description and Business Overview
  • 10.4.3 Sales, Revenue and Market Share of Meloxicam Drug
  • 10.4.4 Meloxicam Drug Product Introduction
  • 10.4.5 Apotex Recent Development
• 10.5 Yung Shin Pharmaceutical
  • 10.5.1 Yung Shin Pharmaceutical Company Details
  • 10.5.2 Company Description and Business Overview
  • 10.5.3 Sales, Revenue and Market Share of Meloxicam Drug
  • 10.5.4 Meloxicam Drug Product Introduction
  • 10.5.5 Yung Shin Pharmaceutical Recent Development
• 10.6 Breckenridge Pharmaceutical
  • 10.6.1 Breckenridge Pharmaceutical Company Details
  • 10.6.2 Company Description and Business Overview
  • 10.6.3 Sales, Revenue and Market Share of Meloxicam Drug
  • 10.6.4 Meloxicam Drug Product Introduction
  • 10.6.5 Breckenridge Pharmaceutical Recent Development
• 10.7 Zydus Pharmaceuticals
  • 10.7.1 Zydus Pharmaceuticals Company Details
  • 10.7.2 Company Description and Business Overview
  • 10.7.3 Sales, Revenue and Market Share of Meloxicam Drug
  • 10.7.4 Meloxicam Drug Product Introduction
  • 10.7.5 Zydus Pharmaceuticals Recent Development
• 10.8 Unichem Pharmaceuticals
  • 10.8.1 Unichem Pharmaceuticals Company Details
  • 10.8.2 Company Description and Business Overview
  • 10.8.3 Sales, Revenue and Market Share of Meloxicam Drug
  • 10.8.4 Meloxicam Drug Product Introduction
  • 10.8.5 Unichem Pharmaceuticals Recent Development
• 10.9 Strides Pharma
  • 10.9.1 Strides Pharma Company Details
  • 10.9.2 Company Description and Business Overview
  • 10.9.3 Sales, Revenue and Market Share of Meloxicam Drug
  • 10.9.4 Meloxicam Drug Product Introduction
  • 10.9.5 Strides Pharma Recent Development
• 10.10 Cipla
  • 10.10.1 Cipla Company Details
  • 10.10.2 Company Description and Business Overview
  • 10.10.3 Sales, Revenue and Market Share of Meloxicam Drug
  • 10.10.4 Meloxicam Drug Product Introduction
  • 10.10.5 Cipla Recent Development
• 10.11 Dr. Reddy's Laboratories
• 10.12 Glenmark Pharmaceuticals
• 10.13 Teva
• 10.14 PuraCap Pharmaceutical
• 10.15 TARO
• 10.16 Lupin Pharmaceuticals
• 10.17 Aurobindo Pharma

11 Value Chain and Sales Channels Analysis

• 11.1 Value Chain Analysis
• 11.2 Sales Channels Analysis
  • 11.2.1 Meloxicam Drug Sales Channels
  • 11.2.2 Meloxicam Drug Distributors
• 11.3 Meloxicam Drug Customers

12 Market Forecast

• 12.1 Global Meloxicam Drug Sales and Revenue Forecast 2019-2025
• 12.2 Global Meloxicam Drug Sales Forecast by Type
• 12.3 Global Meloxicam Drug Sales Forecast by Application
• 12.4 Meloxicam Drug Forecast by Regions
  • 12.4.1 Global Meloxicam Drug Sales Forecast by Regions 2019-2025
  • 12.4.2 Global Meloxicam Drug Revenue Forecast by Regions 2019-2025
• 12.5 United States Market Forecast
• 12.6 European Union Market Forecast
• 12.7 China Market Forecast
• 12.8 Rest of World
  • 12.8.1 Japan
  • 12.8.2 Korea
  • 12.8.3 India

13 Research Findings and Conclusion

14 Appendix

• 14.1 Research Methodology
  • 14.1.1 Methodology/Research Approach
    • 14.1.1.1 Research Programs/Design
    • 14.1.1.2 Market Size Estimation
    • 14.1.1.3 Market Breakdown and Data Triangulation
  • 14.1.2 Data Source
    • 14.1.2.1 Secondary Sources
    • 14.1.2.2 Primary Sources
• 14.2 Author Details

Meloxicam (Mobic) is used to treat pain or inflammation caused by osteoarthritis or rheumatoid arthritis. 
In 2019, the market size of Meloxicam Drug is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Meloxicam Drug.

This report studies the global market size of Meloxicam Drug, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Meloxicam Drug sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
Boehringer-Ingelheim
TerSera Therapeutics
Iroko Pharmaceuticals
Apotex
Yung Shin Pharmaceutical
Breckenridge Pharmaceutical
Zydus Pharmaceuticals
Unichem Pharmaceuticals
Strides Pharma
Cipla
Dr. Reddy's Laboratories
Glenmark Pharmaceuticals
Teva
PuraCap Pharmaceutical
TARO
Lupin Pharmaceuticals
Aurobindo Pharma

Market Segment by Product Type
Tablet
Capsule

Market Segment by Application
Osteoarthritis in adults (OA)
Rheumatoid Arthritis in adults (RA)
Pediatric patients

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Meloxicam Drug status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Meloxicam Drug manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Meloxicam Drug are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025